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Abstract: Prostate cancer is the most commonly diagnosed cancer among American men. The 
multiple treatment options for localized prostate cancer and potential side effects can complicate 
the decision-making process. We describe the level of engagement and communication among 
the patient, family member, and physician (the decision-making “triad”) in the decision process 
prior to treatment. Using the Family and Cancer Therapy Selection (FACTS) study baseline 
survey data, we note racial/ethnic variations in communication among the triad. Sensitivity to 
and awareness of decision-making styles of both the patient and their family member (or care-
giver) may enable clinicians to positively influence communication exchanges about important 
clinical decisions.
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Introduction
Each year, approximately 186 000 men are diagnosed with prostate cancer1 mak-
ing it the most prevalent cancer among men in the USA. Once diagnosed, men with 
prostate cancer face difficult choices about their care given the lack of clinical con-
sensus about prostate cancer management and the uncertainty of benefits from each 
treatment option.2
Without definitive clinical guidelines and strong evidence to support one treatment 
over another, most professional organizations encourage a shared decision-making 
approach in which a patient and his health care provider interact to determine the best 
management for the patient. However, due to the many treatment options available 
and potential mild to severe side effects of each treatment modality, patients may often 
receive complex and sometimes conflicting information from several sources about 
treatment and quality of life posttreatment.
In addition to recommendations from physicians, patient decisions and prefer-
ences are also often influenced by family members and other caregivers.3 Cultural 
differences in communication style may play a role in whether, and to what extent, 
patients discuss treatment decisions with spouses/caregivers.4,5 Our aim is to describe 
racial/ethnic tendencies in the level of engagement and communication among the 
patient, family member, and physician (the decision-making “triad”) prior to   selecting 
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Method
We analyzed data from the Family and Cancer Therapy 
Selection (FACTS) study, a multisite study designed to 
prospectively examine the treatment decision-making 
process of patients newly diagnosed with localized pros-
tate cancer, along with their family members and their 
physicians. Men with incident localized prostate cancer 
(n = 240) and their family members (n = 193) were recruited 
at diagnosis from urology practice sites in California, South 
Carolina, and Texas and invited to participate in separate 
take-home baseline surveys prior to treatment. Urologists 
also completed a brief survey after the treatment planning 
visit. More details of the survey and study design have been 
described previously.6 All study methods and materials were 
reviewed and approved by Institutional Review Boards at 
the Centers for Disease Control and Prevention (CDC), the 
Fred Hutchinson Cancer Research Center study coordinating 
center, and at each recruitment site.
Analysis
For this analysis, patients were not included if they did not 
have a corresponding family member. Therefore, all 193 fam-
ily members were paired with patients. To cover all points of 
the decision-making triad (patient/provider/family member), 
patient–partner pairs were included in further analyses only 
if family members had contact with a provider, resulting in 
161 response pairs for analysis.
Analyses were descriptive. We identified questions from 
patient and family member baseline surveys that illustrated 
the perceived role of the respondent and/or level of com-
munication in the decision-making process among “triad” 
members, specifically between the patient and the family 
member, patient and the physician, and the family member 
and the physician. We describe differences in response by 
race and ethnicity using SAS version 9.2 (SAS Institute, 
Inc, Cary, NC).
Results
Due to the small number of African-American and 
Hispanic patients and family members participating in 
this survey (Table 1), we present only descriptive results. 
Overall, more men were white (71%), were married or 
living with a partner (84%), and were in a higher (over 
US$75 000) income bracket (49%). Sixty-five percent 
were aged 60 and older. Most (93%) of the participating 
family members were spouses/partners. Most (95%) men 
had some form of health insurance and about 50% had at 
least a college   education (Table 1).
Across all races, most ($75%) patients reported that 
the physician “definitely” involved them in the decision-
making process, “definitely” discussed treatment options in 
an understandable way, or “definitely” encouraged questions 
about treatment options (Table 2). From the patient perspec-
tive, although some patients (58% across all races) found 
wife/partner preference for a particular treatment “very 
important,” a greater proportion of African-American men in 
Table 1 Demographic characteristics of prostate cancer patients 
and their family members
Total Patients Family 
members
N % N %
Total 240 193
Age
 , 60 85 35% 100 52%
  60–64 57 24% 36 19%
  65–69 56 23% 31 16%
  $70 42 18% 20 10%
Sex
  Female 187 97%
Relationship with patient
  Wife/Partner 179 93%
  Daughter/Son 9 5%
  Other/Unknown 5 3%
Race
  White 170 71% 134 69%
  Black 38 16% 24 12%
  hispanic 26 11% 17 9%
  Other/Unknowna 6 3% 18 9%
Insurance
  Medicare 93 39%
  Private (non-Medicare) 96 40%
  VA/Military 36 15%
  None/Unknown 11 5%
Employment
  Full time 104 43%
  Part-time/Self-employed 45 19%
  Retired 81 34%
  Unemployed/Unknown 10 4%
Income (USD)
 , $40 000 68 28%
  $40 000–$74 999 48 20%
 $ $75 000 117 49%
Education
  high school or less 50 21% 36 19%
  Some college 65 27% 64 33%
  College graduate 59 25% 62 32%
  Graduate degree 61 25% 30 16%
Marital status
  Married or living with a partner 202 84% 180 93%
  Other/Unknown 38 16% 13 7%
Notes: aPatients of “other/unknown” race were Asian (n = 6). Among family members 
of “other/unknown” race, twelve were Asian and six were of unknown race.
Percentages may not all total 100% because of missing data.
Abbreviation: VA, Veteran Affairs.International Journal of General Medicine 2011:4 submit your manuscript | www.dovepress.com
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particular (74%) valued the importance of their wife/partner   
and a close family member’s preference (47%) (Table 2). 
Most ($80%) patients, regardless of race, considered recom-
mendations from their doctor “very important.”
Family members generally felt “very comfortable” discuss-
ing cancer issues with the physician and attended physician’s 
visits “often” after patient diagnosis (Table 2). Much like the 
patients, a high proportion of family members also affirmatively 
reported that the physician “definitely” discussed treatment 
options in an understandable way and encouraged questions. 
However, African-American family members more frequently 
reported that physicians “definitely” encouraged them to ask 
questions about treatment options (African-Americans 95%; 
whites 77%; Hispanics 76%). Family members reported dis-
cussing treatment options with patients “very often” among 
26% of African-American, 41% of Hispanic, and 51% of white 
families. Although discussion occurred less often between the 
family member and physician alone (African-Americans 21%; 
whites 12%; Hispanics 0%), a greater proportion of African-
American family members reported having independent con-
versations with the physician than whites.
Lastly, we assessed how family members viewed their 
role in treatment decision-making. Nearly all family members 
(97%) “strongly agreed” their role was to listen and provide 
emotional support, and the majority of family members (82%) 
“strongly agreed” their role was to help get information about 
cancer and treatment options (Figure 1). A greater proportion 
of Hispanic family members “strongly agreed” that their role 
was to arrange meetings with physicians and other health 
professionals (Hispanics 71%, African-  Americans 58%, 
whites 52%), as well as to help weigh pros and cons of each 
treatment option (Hispanics 88%, whites 80%, African-
Americans 74%). Slightly more African-American (79%) and 
Hispanic (71%) than white (65%) family members “strongly” 
felt their role was to help patients make a treatment decision. 
Our results were not statistically significant at P , 0.05.
Discussion
Communication is a complex process, involving multilevel 
interactions, understanding of the content of discussion, and the 
relational aspects of cultures and behaviors, which are critical 
to the decision-making process and for ensuring comprehen-
sive, quality cancer care and outcomes.7,8 Our data provide 
insight into the interaction and engagement of the patient, 
family member, and physician around treatment-related deci-
sions for localized prostate cancer by race/ethnicity. Variations 
in communication and interaction styles among the triad of 
decision-makers can be important considerations for further 
investigations into providing culturally sensitive communica-
tion concerning prostate cancer treatment.
Results from our study show that, overall, most patients 
and family members felt that their physician “definitely” 
encouraged involvement in decision-making and that treat-
ment options were discussed in an understandable way. Still, 
most patients highly regarded the opinions/recommendations 
of their physician, suggesting that the patient’s treatment 
decision may ultimately have relied on the recommendation 
of their urologist.9,10 Although our data did not directly assess 
Table 2 Communication in decision-making process among the triad (patient, physician, family member) by race/ethnicity
Triad relationship Race/ethnicity
White  
(n = 125)
African-American  
(n = 19)
Hispanic   
(n = 17)
Patient–physician (n = 173)
Physicians “definitely” involved me in the decision process 74% 84% 82%
Physicians “definitely” discussed treatment options in an understandable way 84% 89% 100%
Physicians “definitely” encouraged me to ask questions about treatment options 79% 89% 88%
Physician recommendation “very important” 86% 89% 94%
FM–physician (n = 161)
Physicians “definitely” discussed treatment options in an understandable way 90% 89% 76%
Physicians “definitely” encouraged me to ask questions about treatment options 77% 95% 76%
Communicated with physicians on my own 12% 21% 0%
FM “very comfortable” discussing cancer issues with physician 85% 79% 82%
Patient–FM (n = 161)
Patient considers wife/partner preference for a particular treatment “very important” 54% 74% 71%
Patient considers close FM preference for a particular treatment “very important” 21% 47% 24%
FM discussed treatment options “very often” with patient 51% 26% 41%
FM attended physician visits “often” after diagnosis 78% 79% 82%
Note: hispanic denoted in addition to racial status.
Abbreviation: FM, family member.International Journal of General Medicine 2011:4 submit your manuscript | www.dovepress.com
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this dynamic, such behavior is not unusual given that physi-
cians are often called upon for their expertise and experience 
and have historically been entrusted to make medical deci-
sions in the best interest of the patient.11 While previously, 
men may have taken a more passive role in selecting their 
treatment12 following the guidance of their physician, more 
recent studies suggest that men prefer greater involvement/
collaboration in treatment decision-making for localized pros-
tate cancer13–15 and tend to be more satisfied with their role 
in the decision-making given individualized information.16 
Although men seem to prefer to be increasingly involved in 
their care, we observed that most men in our study continue 
to regard physician opinions highly. These interactions in the 
decision-making process are important to monitor as studies 
have shown the aggressiveness of the treatment (level of 
toxicity) selected for prostate cancer can often depend on 
the assertiveness of the managing physician and can differ 
from physician’s predictions for patients’ preferences.17,18 
Additionally, treatment-specific decisions could over time 
increase the patient’s decisional regret following prostate 
cancer treatment.19
Communicating and collaborating with family members 
(usually spouses) and other caregivers of patients with cancer 
also affect the cancer diagnosis and treatment experience. 
Lack of communication about prostate cancer between 
spouses has been shown to negatively impact patient–partner 
satisfaction and adjustment to treatment-related issues.20 
Effective communication in the level of information provided 
and interpersonal behaviors between the physician–patient 
and family members, could improve satisfaction for both 
the provider and patient.21 Although it is debatable to what 
extent family members (spouse) influence a patient’s final 
decision about treatment, a spouse’s presence is important 
for the roles they play in obtaining information, providing 
emotional support, and aiding in decisions. Our data support 
that many family members strongly perceive responsibility 
100%
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in providing this type of caregiving assistance to the patient, 
in weighing the pros and cons of each treatment option, 
and in helping the patient make a treatment decision.
Race/ethnicity and cultural background have critical bear-
ing on how cancer is discussed and processed individually 
and in partnership.4 Our findings showed there were racial/
ethnic variations in communication among the triad, although 
not statistically significant at P = 0.05. African-American 
family members more frequently reported feeling encouraged 
to ask questions about treatment options and also tended to 
report having independent conversations with the physician 
compared with whites. Family members of African-American 
patients reported fewer discussions about treatment options 
with the patient and appeared to perceive a stronger role in 
decision-making than white family members. Comparatively, 
African-American patients also valued recommendations of 
their family member more than white patients. Although our 
data for this population are sparse, a similarly higher propor-
tion of Hispanic family members compared with all other 
race/ethnicities “strongly agreed” their role was to support 
the patient by helping to arrange meetings with doctors and 
weigh the pros and cons of each treatment option.
Other studies that have characterized family involvement 
with prostate cancer treatment decisions among African-
American prostate cancer survivors have also shown that 
men particularly value their wives’ opinions about the best 
treatment option and that family members generally play an 
important role in making decisions about the treatment the 
men receive.22 Our data seem to indicate similar findings. 
Furthermore, focus groups conducted by Williams et al found 
that African-American participants emphasized that effective 
communication involved “knowing” and “understanding” the 
patient and family individually so that communication could 
be tailored through this relationship.5 Also, African-American 
focus group participants (a mixture of caregivers and cancer 
survivors) preferred participating in the decision-making pro-
cess as it equated to having a “sense of control.”5 This cultural 
aspect may explain the higher level of participation we observed 
among African-American family members in engaging with 
the physician.
There are several limitations to this study. First, commu-
nication among the triad is a complex process and one that is 
difficult to comprehensively measure and accurately attribute. 
Our questions only serve as a proxy to the shared decision-
making process and the content, depth, and level of discussion 
that should have appropriately taken place. Second, the sample 
size was rather small for African-American and Hispanic 
participants and did not allow for more detailed analyses of 
these   subpopulations, and therefore the inferences that can be 
concluded are limited. As such, there is a possibility of selec-
tion bias, and these results should be replicated in a larger 
population-based study. Third, we were unable to compare 
the participants who responded to our survey with those who 
received it but chose not to complete the survey to assess the 
impact of nonresponse bias. Those who agreed to participate 
may be different from nonparticipants in their behaviors, atti-
tudes, and interest in engaging in decision-making. Despite 
these limitations, our study is one of few studies that have 
characterized racial/ethnic differences in communication pref-
erences from paired surveys. We believe that the results of this 
study provide helpful information about communication and 
interaction preferences among the triad of decision-makers.
Understanding the dynamics of partner communication 
and physician interaction is an important part of improving 
outcomes in clinical practice by aiding patients and their 
family members in making appropriate health- and treatment-
related decisions. Considering the cultural, interpersonal, and 
decision-making styles of patients and their family members 
can help clinicians facilitate improved understanding of can-
cer management for their patients. Burkhalter and Bromberg 
previously outlined and advocated for further evaluation of 
cultural effects on patient–family member–physician com-
munication.21 Our results suggest variation in prostate cancer 
treatment-related discussions can differ by race/ethnicity and 
may substantiate the need for further research on how cultural 
influences (including faith and beliefs) and communicative 
behavior affect discussions and decisions about cancer treat-
ment and outcome.
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